Derek Lowe on "Peptides"

The buzz—and the definition

Chemist Derek Lowe took aim at the hype around so‑called “peptides” in a recent post, cutting through the marketing fog. For scientists, a peptide is simply a short chain of amino acids; the number of possible sequences is astronomically large. Lowe points out that many such chains are biologically active — and many more do nothing at all. So when people talk about taking “peptides” as if that's a single, well‑defined category, a puzzled look is the sane reaction.

Mail‑order wonder drugs? Buyer beware

It has been reported that suppliers are marketing mail‑order peptides as cure‑alls — energizers, fat‑melters, muscle builders, hair growers, life‑extenders. Allegedly, these products arrive for self‑injection, because most peptides would be destroyed if taken orally. That’s a big shift in perception: GLP‑1 drugs and other injectables have normalized injections for some, but normalization is not the same as safety. Who wouldn’t be tempted? Still, the promise of a quick fix is often too good to be true.

Science, stability and real risks

Lowe’s bottom line is sobering: the science is a mixed bag. Yes, researchers are finding potent biological activities in short peptides. No, we do not understand most of those effects well enough to start sticking needles in ourselves. The body is awash in enzymes that chew up peptide bonds; stability and off‑target effects remain major unknowns. This is the emotional crux of the story — excitement meeting uncertainty — and it’s where caution should come in. Regulators and clinicians will need to catch up if this market keeps running ahead of hard data.

Sources: science.org, Hacker News